|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
WO2001032621A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Wakunaga Pharmaceutical Co., Ltd. |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
IL158168A0
(en)
*
|
2001-04-16 |
2004-03-28 |
Tanabe Seiyaku Co |
5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
|
|
BRPI0211844B8
(pt)
|
2001-08-10 |
2021-05-25 |
Nippon Chemiphar Co |
composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
|
|
CN1293076C
(zh)
|
2001-10-12 |
2007-01-03 |
日本化学医药株式会社 |
过氧化物酶体增殖剂应答性受体δ的活化剂
|
|
US8013006B2
(en)
*
|
2004-07-14 |
2011-09-06 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
AU2005296305A1
(en)
*
|
2004-10-12 |
2006-04-27 |
Decode Genetics Ehf |
Sulfonamide peri-substituted bicyclics for occlusive artery disease
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
ES2461268T3
(es)
*
|
2006-02-15 |
2014-05-19 |
Allergan, Inc. |
Compuestos de amida, éster, tioamida y tioléster de ácido indol-3-carboxílico que portan grupos arilo o heteroarilo que tienen actividad biológica antagonista del receptor de esfingosina-1-fosfato (S1P)
|
|
JP5290749B2
(ja)
|
2006-04-18 |
2013-09-18 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
EP2027117A2
(en)
*
|
2006-05-16 |
2009-02-25 |
Decode Genetics EHF |
Process for preparing 7-(acryloyl)-indoles
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
AU2008206495A1
(en)
*
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having Sphingosine-1-Phosphate (S1P) receptor antagonist biological activity
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
EP2277874B1
(en)
|
2008-04-15 |
2018-06-27 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
CN104710385B
(zh)
|
2010-03-12 |
2018-11-09 |
奥默罗斯公司 |
Pde10抑制剂以及相关组合物和方法
|
|
CN103649079B
(zh)
|
2010-12-22 |
2016-11-16 |
Abbvie公司 |
丙型肝炎抑制剂及其用途
|
|
KR20150119871A
(ko)
|
2013-02-21 |
2015-10-26 |
아드베리오 파마 게엠베하 |
메틸 ｛4,6-디아미노-2-[1-(2-플루오로벤질)-1H-피라졸로[3,4-b]피리디노-3-일]피리미디노-5-일｝메틸 카르바메이트의 형태
|
|
NZ630803A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
WO2016033445A1
(en)
*
|
2014-08-29 |
2016-03-03 |
Chdi Foundation, Inc. |
Probes for imaging huntingtin protein
|
|
AU2016250843A1
(en)
|
2015-04-24 |
2017-10-12 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
US9920045B2
(en)
|
2015-11-04 |
2018-03-20 |
Omeros Corporation |
Solid state forms of a PDE10 inhibitor
|
|
KR102349776B1
(ko)
|
2017-11-17 |
2022-01-10 |
셀릭스 바이오 프라이빗 리미티드 |
눈 질환의 치료를 위한 조성물 및 방법
|